NCT00412932

An Examination of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Elderly Patients With Hypertension

A Prospective, Open Label, Single Arm Study to Evaluation the Safety and Efficacy of an Olmesartan Medoxomil Based Treatment Regimen in Elderly Patients With Hypertension

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 178 (actual)
• Sponsor: Daiichi Sankyo · Industry
• Sex: All
• Age: 65 Years
• Healthy volunteers: Not accepted

Summary

This 14 week study will examine the ability of olmesartan medoxomil to lower the blood pressure of patients 65 years of age or older with high blood pressure. The medication being tested has been approved by the FDA for the treatment of high blood pressure.

Conditions

• Hypertension

Interventions

Type	Name	Description
DRUG	Olmesartan medoxomil	Tablets
DRUG	Olmesartan medoxomil/hydrochlorothiazide	Tablets

Timeline

• Start date: 2006-12-01
• Primary completion: 2008-04-01
• Completion: 2008-04-01
• First posted: 2006-12-19
• Last updated: 2009-09-22
• Results posted: 2009-09-11

Locations

29 sites across 1 country: United States